An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.
The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.
References
Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).
Recent Posts
In Memoriam: Jerry Northern, PhD
Dr. Jerry Northern made incomparable contributions to his profession and to the American Academy of Audiology throughout his career. His recent passing is a loss…
AMA RUC Upcoming Surveys
Over the next several weeks, a significant number of CPT® codes used to report audiology function tests will undergo review through the AMA/Specialty Society Relative…
Motion Intolerance Causes and Treatment Options
A recent online publication (Shevtsov, 2026) discussed ways to manage motion intolerance. Motion intolerance, also known as motion sickness, is theorized to occur when there…



